📑Supply of Micafungin (Mycamine).
Procurement process summary
This process is to purchase Supply of Micafungin (Mycamine).
This contract was awarded by 🇪🇺 Golden Jubilee Hospital (National Waiting Times Centre Board) for an amount of GBP 491,682 to 1 supplier. It was published on 2013-11-13 through direct
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇺 Golden Jubilee Hospital (National Waiting Times Centre Board) Buying unitnot reported Publication date2013-11-13 Contest statusnot reported DescriptionThe supply of Micafungin (Mycamine) to Health Boards across NHS Scotland.Awards
This award was granted to Astellas by Golden Jubilee Hospital (National Waiting Times Centre Board) for an amount of GBP 491,682. The procurement process was conducted through direct for the category of goods. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇬🇧 Astellas | GBP 491,682 | 1 |
Market context and opportunities
The execution of this contract allows the entity Golden Jubilee Hospital (National Waiting Times Centre Board) to fulfill its public service objectives efficiently.
The direct purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberEU_ocds-70d2nz-1905e9cc-96c4-4868-8555-8d424e32544e-award-1Publication date2013-11-13Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalitydirectMethod detailsf03_award_without_prior_publicationStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
